Neurocrine Biosciences
NBIX
NBIX
367 hedge funds and large institutions have $7.91B invested in Neurocrine Biosciences in 2020 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 139 increasing their positions, 140 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less funds holding
Funds holding: 391 → 367 (-24)
17% less capital invested
Capital invested by funds: $9.56B → $7.91B (-$1.66B)
33% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 63
Holders
367
Holding in Top 10
9
Calls
$62.4M
Puts
$53.4M
Top Buyers
| 1 | +$64.1M | |
| 2 | +$56.1M | |
| 3 | +$49.6M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$43.9M |
| 5 |
JPMorgan Chase & Co
New York
|
+$36.2M |
Top Sellers
| 1 | -$62.4M | |
| 2 | -$47.5M | |
| 3 | -$31.1M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$26.5M |
| 5 |
Millennium Management
New York
|
-$23.3M |